Cargando…
COVID-19 necrotising pneumonia and extracorporeal membrane oxygenation: a challenge for anticoagulation
ECMO and curative anticoagulation may be associated with severe bleeding events in #COVID19 pneumonia. ECMO and high levels of anticoagulation must be considered with caution in the most severe patients with #SARS-CoV-2 necrotising pneumonia. https://bit.ly/3clhu31
Autores principales: | Goursaud, Suzanne, Mombrun, Martin, du Cheyron, Damien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335839/ https://www.ncbi.nlm.nih.gov/pubmed/32665949 http://dx.doi.org/10.1183/23120541.00182-2020 |
Ejemplares similares
-
Corticosteroid use in selected patients with severe acute respiratory distress syndrome related to COVID-19
por: Goursaud, Suzanne, et al.
Publicado: (2020) -
Mediastinal lymphadenopathy in patients with severe COVID-19
por: Valette, Xavier, et al.
Publicado: (2020) -
Ultraprotective ventilation allowed by extracorporeal CO(2) removal improves the right ventricular function in acute respiratory distress syndrome patients: a quasi-experimental pilot study
por: Goursaud, Suzanne, et al.
Publicado: (2021) -
Anticoagulation on extracorporeal membrane oxygenation (ECMO)
por: Khilnani, Praveen
Publicado: (2017) -
Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation
por: Rieder, Marina, et al.
Publicado: (2020)